452,081,061 WBA Walgreens NASDAQ After Hours 18 Feb 2026: Active session, price $11.98

WBA stock traded at $11.98 in after-hours on 18 Feb 2026 with 452,081,061.00 shares changing hands, a clear volume spike that dominated the session. We saw a modest bid lift from the previous close of $11.92, but the headline is the volume and elevated short-interest chatter that pushed traders to reprice risk. On the NASDAQ in the United States, the stock sits between a 52-week high of $13.25 and low of $8.08. We break down the price drivers, valuation, and what the heavy after-hours activity means for near-term trade and longer-term WBA stock investors.

After-hours price action and volume for WBA stock

The most important fact is the trade size: 452,081,061.00 shares in after-hours, far above the average volume of 16,940,296.00, which signals concentrated activity. This surge suggests block trades or high short-covering, not routine retail flows.

WBA stock closed the regular session at $11.92 and held $11.98 in after-hours, leaving intraday range tight but momentum visible in volume. The 50-day average price is $11.66 and the 200-day average is $10.81, both below current levels, indicating short-term strength versus longer-term trend.

Earnings, valuation and core financials for Walgreens Boots Alliance

Walgreens Boots Alliance reported trailing EPS of -7.29 and a trailing PE of -1.64, reflecting recent net losses and legacy non-operating items. Revenue per share stands at 178.73 while book value per share is 8.46, yielding a price-to-book near 1.44 on NASDAQ in USD.

Free cash flow per share is 0.67 and operating cash flow per share is 1.82, showing positive cash generation despite earnings headwinds. Debt-to-equity is 4.04 and enterprise value to sales is 0.25, highlighting a leveraged balance sheet that investors must watch.

Technical setup and trading signals for WBA stock

Momentum indicators show an extreme RSI reading of 100.00, and ADX at 50.00, signaling a strong and possibly overbought short-term trend. Average True Range is 0.16 indicating low price range per day recently.

Price sits above the 50-day and 200-day averages, with on-balance volume reflecting the after-hours spike at 452,081,061.00. Traders should watch support near the 200-day average $10.81 and resistance at the 52-week high $13.25.

Meyka AI grade, model forecast and scenario view

Meyka AI rates WBA with a score out of 100: Meyka AI rates WBA with a score of 61.80 out of 100, grade B, suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects $4.08 for the comparable yearly output, which implies an approximate downside of -65.97% versus the current price of $11.98. Forecasts are model-based projections and not guarantees; they reflect downside scenarios under slower recovery and continued margin pressure.

Analyst views, price targets and recent WBA news

Public analyst coverage is mixed: consensus derived from recent data shows 0 Strong Buys, 0 Buys, 1 Hold and 2 Sells, translating to a consensus score near 2.00. Recent MarketBeat coverage lists a current price target of $9.00 for WBA MarketBeat forecast.

Short-interest updates and institutional activity are active topics this session; MarketBeat short interest notes recent changes that likely fed the heavy after-hours volume MarketBeat short interest. We include those inputs when framing our near-term trade outlook.

Risks and opportunities for WBA stock investors

Key risks include high leverage (debt-to-equity 4.04), negative EPS -7.29, and operating margin pressure shown by a trailing operating margin near -2.02%. These metrics increase downside sensitivity if retail and pharmacy volumes slow.

Opportunities center on cash flow recovery—free cash flow yield is 5.59%—and the company’s scale in pharmacy retail across the United States and international markets in the Healthcare sector. Any operational improvement or asset sales could materially change valuation multiples.

Final Thoughts

WBA stock is trading with exceptional after-hours volume and modest price change, forcing a re-evaluation of both short-term trading and longer-term recovery scenarios. We note core problems: negative EPS -7.29, high debt-to-equity 4.04, and a mixed analyst stance with a recent MarketBeat price target near $9.00. Meyka AI’s model projects $4.08, which implies an estimated downside of -65.97% from the current $11.98. That projection is a model output, not a guarantee. For traders, the after-hours volume spike signals short-covering or block activity and offers intraday trading range opportunities between $10.81 (200-day average) and $13.25 (52-week high). For longer-term investors, watch cash flow trends, debt reduction progress, and upcoming earnings announcements. We use Meyka AI as an AI-powered market analysis platform to add model context but recommend investors build position sizing and risk controls aligned with portfolio goals and the stock’s leverage and volatility profile.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.